Medical Director, Vascular Care
Renown Institute for Heart and Vascular Health
reno, Nevada, United States
Dr. Bloch serves as Medical Director of Vascular Medicine and Anticoagulation Services at the Renown Medical Center Institute for Heart and Vascular Health. Dr. Bloch has served as a principal investigator on numerous clinical trials, most recently focused in the field of device therapy for hypertension and novel lipid lowering drugs. His academic work has been published in multiple journals and textbooks, and he is currently the co-author of the UpToDate hypertension page. He is a frequent participant in educational projects around the nation and internationally, focused on best practices in the management of hypertension, dyslipidemia, anticoagulation, vascular disease, and heart disease and stroke prevention.
Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)
RENAL DENERVATION TREATMENT FOR UNCONTROLLED HYPERTENSION | INNOVATIVE TECHNOLOGY UPDATE
Sunday, March 9, 2025
8:00 AM – 9:56 AM ET
Understanding Benefits of Recently Approved Renal Denervation Devices
Sunday, March 9, 2025
8:16 AM – 8:24 AM ET
Redesigning Hypertension Clinical Trials for Devices and Drugs
Sunday, March 9, 2025
10:52 AM – 11:00 AM ET
Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation
Sunday, March 9, 2025
11:56 AM – 12:15 PM ET
Tuesday, March 11, 2025
9:30 AM – 9:50 AM ET